股本结构
单位：万股
| 公告日期 | 2025-06-02 | 2022-10-31 | 2021-11-22 | 2021-10-29 | 2021-08-20 | 2021-07-20 |
|---|---|---|---|---|---|---|
| 证券总股本 | 49448.89 | 1301.29 | 1296.71 | 1264.21 | 1296.71 | 1264.21 |
| 普通股本 | 49448.89 | 1301.29 | 1296.71 | 1264.21 | 1296.71 | 1264.21 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-06-16 | 2022-06-30 | 2021-11-22 | 2021-10-29 | 2021-08-20 | 2021-07-16 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-06-02 | 49448.89 | 未披露 |
更多>>
a 38-for-one forward stock split of Ordinary Shares.
|
2025-06-16 |
| 2022-10-31 | 1301.29 | 未披露 |
更多>>
From June 30, 2021 to June 30, 2022
Exercise of warrants
Issuance of shares upon initial public offering and over allotment, net
Issuance of shares upon conversion of convertible bonds
|
2022-06-30 |
| 2021-11-22 | 1296.71 | 未披露 | 定期报告 | 2021-11-22 |
| 2021-10-29 | 1264.21 | 未披露 | 定期报告 | 2021-10-29 |
| 2021-08-20 | 1296.71 | 未披露 |
更多>>
1.Regencell Bioscience Holdings Limited today announced that the underwriter of its initial public offering (the “Offering”) had exercised its option to purchase 325,000 additional ordinary shares at the public offering price of US$9.50 per share to cover over-allotments.
|
2021-08-20 |
| 2021-07-20 | 1264.21 | 未披露 |
更多>>
1.Ordinary Shares offered by company 2,300,000 Ordinary Shares
2.The number of Ordinary Shares that are and will be outstanding immediately before and after this offering as shown above is based on 10,000,000 shares outstanding as of June 9, 2021
|
2021-07-16 |
a 38-for-one forward stock split of Ordinary Shares.
From June 30, 2021 to June 30, 2022
Exercise of warrants
Issuance of shares upon initial public offering and over allotment, net
Issuance of shares upon conversion of convertible bonds
1.Regencell Bioscience Holdings Limited today announced that the underwriter of its initial public offering (the “Offering”) had exercised its option to purchase 325,000 additional ordinary shares at the public offering price of US$9.50 per share to cover over-allotments.
1.Ordinary Shares offered by company 2,300,000 Ordinary Shares
2.The number of Ordinary Shares that are and will be outstanding immediately before and after this offering as shown above is based on 10,000,000 shares outstanding as of June 9, 2021